CN103006962B - Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation - Google Patents

Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation Download PDF

Info

Publication number
CN103006962B
CN103006962B CN201310010585.0A CN201310010585A CN103006962B CN 103006962 B CN103006962 B CN 103006962B CN 201310010585 A CN201310010585 A CN 201310010585A CN 103006962 B CN103006962 B CN 103006962B
Authority
CN
China
Prior art keywords
grams
chinese medicine
gram
herba
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310010585.0A
Other languages
Chinese (zh)
Other versions
CN103006962A (en
Inventor
韩洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310010585.0A priority Critical patent/CN103006962B/en
Publication of CN103006962A publication Critical patent/CN103006962A/en
Application granted granted Critical
Publication of CN103006962B publication Critical patent/CN103006962B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation, which can effectively solve the problem of a medicine for treating the osteoproliferation and the lumbar disc herniation. The technical scheme is that the traditional Chinese medicine liquid is prepared from following raw material traditional Chinese medicines by weight: 45-55 g of safflower carthamus, 27-33 g of angelica sinensis, 8-12 g of monkshood, 13-17 g of ledebouriella seseloides wolff, 13-17 g of ground beeltle, 17-23 g of garden balsam stem, 13-17 g of lycopodium clavatum, 13-17 g of folium artemisiae argyi, 13-17 g of red-spotted stonecrop pseudo-ginseng, 17-23 g of ligusticum wallichii, 13-17 g of caulis spatholobi, 13-17 g of daemonorops draco, 13-17 g of scorpio, 8-12 g of centipede and 17-23 g of rhizoma drynariae. The medicines are mixed together and then are immersed by white spirit with the concentration of 45-65 degrees at 10-35 DEG C for 25-35 days to obtain the traditional Chinese medicine liquid processed with wine. The traditional Chinese medicine liquid disclosed by the invention is reasonable in formula and all components support each other; and the traditional Chinese medicine liquid has the effects of promoting blood circulation to remove blood stasis, diminishing inflammation and relieving pain, and clearing and activating the channels and collaterals, can be effectively used for treating the osteoproliferation and the lumbar disc herniation, and has the advantages of fast effect, good effect, low cost and convenience for use.

Description

The external application Chinese medicine liquid for the treatment of hyperosteogeny, prolapse of lumbar intervertebral disc
Technical field
The present invention relates to Chinese medicine, particularly a kind of external application Chinese medicine liquid (claiming again bone health liquid) for the treatment of hyperosteogeny, prolapse of lumbar intervertebral disc.
Background technology
Bone matrix hyperplasia is called again hyperplastic osteoarthritis, osteoarthritis, degenerated arthrosis, senile arthritis, hypertrophiarthritis, is due to the cartilage that forms joint, intervertebral disc, the soft tissue degeneration such as ligament, degenerate, edge, joint forms bony spur, and synovial membrane is plump waits variation, and occurs osteoclasia, cause insecondary hyperosteogeny, cause joint deformity, in the time being subject to abnormal load, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Hyperosteogeny is a kind of frequently-occurring disease, and commonly encountered diseases is particularly commonplace in mid-aged population.
Intervertebral disc prolapse is a kind of frequently-occurring disease, commonly encountered diseases, and it is mainly because of intervertebral disc strain degeneration, and Anular disruption or vertebral pulp are deviate from etc., stimulate or compressing spinal nerves the series of symptoms group that spinal cord etc. cause.Adult's intervertebral disc generation degenerative change, the fibre thickening in fibrous ring, becomes fragile so that eventual failure, makes intervertebral disc lose original elasticity, can not undertake the pressure of originally bearing.In excessive strain, position cataclysm, under action or violence are clashed into sudden force, fibrous ring gets final product outside bulging, outwards outstanding thereby vertebral pulp also can pass through the crack of the fibrous ring of breaking.
Although the hyperosteogeny at each position, intervertebral disk hernia impact is different, and most patients, still take Drug therapy as first-selected, by Drug therapy relief of symptoms, remove edema and inflammatory reaction, make the nerve of pressurized, and the synovial membrane of angioedema likely recovers.Western medicine class drug main Yao Yi town pain anti-inflammatory agent is main, and western medicine eases the pain, and the reaction that controls inflammation, improves function of joint.Motherland's traditional medicine is bone matrix hyperplasia, and intervertebral disc prolapse, as the treatment of rheumatism involving the bone disease, is generally divided into the large class of deficiency and excess two on dialectical, and void comprises the hepatic and renal YIN deficiency and weak type of qi and blood, comprises in fact rheumatism it is attacked by the cold and evil, phlegm resistance and qi stagnation and blood stasis type.Therefore treatment by Chinese herbs bone matrix hyperplasia, the multiplex activating blood circulation to dissipate blood stasis of intervertebral disc prolapse and medicine for rheumatism, but these treatment hyperosteogenys, the Chinese medicine preparation component of intervertebral disk hernia is more, has increased treatment cost.Also the employing traction having, massage waits non-drug therapy mode to treat bone and holds hypertrophy disease, but undesirable for patient with severe symptoms's effect.
Summary of the invention
For above-mentioned situation, for overcoming the defect of prior art, the present invention's object is just to provide a kind of external application Chinese medicine liquid for the treatment of hyperosteogeny, prolapse of lumbar intervertebral disc, can effectively solve the medicine for treatment problem of hyperosteogeny, prolapse of lumbar intervertebral disc.
The technical scheme that the present invention solves is, according to Chinese medicine and pharmacy principle, hyperosteogeny, prolapse of lumbar intervertebral disc belongs to arthromyodynia, should be with blood circulation promoting and blood stasis dispelling, anti-inflammatory analgetic, stimulate the menstrual flow and relax network for Therapeutic Principle, accordingly, the present invention adopts the raw material Chinese medicine of following weighing scale to make: Flos Carthami 45-55 gram, Radix Angelicae Sinensis 27-33 gram, Radix Aconiti 8-12 gram, Radix Saposhnikoviae 13-17 gram, Eupolyphaga Seu Steleophaga 13-17 gram, Herba speranskiae tuberculatae 17-23 gram, Herba Lycopodii 13-17 gram, Folium Artemisiae Argyi 13-17 gram, Herba Sedi Aizoon 13-17 gram, Rhizoma Chuanxiong 17-23 gram, Caulis Spatholobi 13-17 gram, Sanguis Draxonis 13-17 gram, Scorpio 13-17 gram, Scolopendra 8-12 gram, Rhizoma Drynariae 17-23 gram, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
Reasonable recipe of the present invention, supports mutually between component, has blood circulation promoting and blood stasis dispelling, anti-inflammatory analgetic, the effect of network of relaxing of stimulating the menstrual flow, and is effective to treat hyperosteogeny, prolapse of lumbar intervertebral disc, instant effect, and effective, cost is low, and medication is convenient.
The specific embodiment
Below in conjunction with embodiment, the specific embodiment of the present invention is elaborated.
Embodiment 1
The present invention is in concrete enforcement, Chinese medicine by following weighing scale is made: 50 grams, Flos Carthami, 30 grams of Radix Angelicae Sinensis, 10 grams of Radix Aconitis, 15 grams of Radix Saposhnikoviaes, 15 grams of Eupolyphaga Seu Steleophagas, 20 grams of Herba speranskiae tuberculataes, 15 grams of Herba Lycopodiis, 15 grams of Folium Artemisiae Argyis, 15 grams of Herba Sedi Aizoons, 20 grams of Rhizoma Chuanxiongs, 15 grams of Caulis Spatholobis, 15 grams of Sanguis Draxonis, 15 grams of Scorpio, 10 grams of Scolopendras, 20 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
Embodiment 2
The present invention also can be made up of the Chinese medicine of following weighing scale: 45 grams, Flos Carthami, 27 grams of Radix Angelicae Sinensis, 8 grams of Radix Aconitis, 13 grams of Radix Saposhnikoviaes, 13 grams of Eupolyphaga Seu Steleophagas, 17 grams of Herba speranskiae tuberculataes, 13 grams of Herba Lycopodiis, 13 grams of Folium Artemisiae Argyis, 13 grams of Herba Sedi Aizoons, 17 grams of Rhizoma Chuanxiongs, 13 grams of Caulis Spatholobis, 13 grams of Sanguis Draxonis, 13 grams of Scorpio, 8 grams of Scolopendras, 17 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
Embodiment 3
The present invention also can be made up of the Chinese medicine of following weighing scale: 55 grams, Flos Carthami, 33 grams of Radix Angelicae Sinensis, 12 grams of Radix Aconitis, 17 grams of Radix Saposhnikoviaes, 17 grams of Eupolyphaga Seu Steleophagas, 23 grams of Herba speranskiae tuberculataes, 17 grams of Herba Lycopodiis, 17 grams of Folium Artemisiae Argyis, 17 grams of Herba Sedi Aizoons, 23 grams of Rhizoma Chuanxiongs, 17 grams of Caulis Spatholobis, 17 grams of Sanguis Draxonis, 17 grams of Scorpio, 12 grams of Scolopendras, 23 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
Embodiment 4
The present invention in the specific implementation, also can be made by the Chinese medicine of following weighing scale: 46 grams, Flos Carthami, 32 grams of Radix Angelicae Sinensis, 9 grams of Radix Aconitis, 16 grams of Radix Saposhnikoviaes, 14 grams of Eupolyphaga Seu Steleophagas, 22 grams of Herba speranskiae tuberculataes, 14 grams of Herba Lycopodiis, 16 grams of Folium Artemisiae Argyis, 14 grams of Herba Sedi Aizoons, 22 grams of Rhizoma Chuanxiongs, 14 grams of Caulis Spatholobis, 16 grams of Sanguis Draxonis, 14 grams of Scorpio, 11 grams of Scolopendras, 18 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
Embodiment 5
The present invention also can be made up of the Chinese medicine of following weighing scale: 53 grams, Flos Carthami, 28 grams of Radix Angelicae Sinensis, 11 grams of Radix Aconitis, 14 grams of Radix Saposhnikoviaes, 16 grams of Eupolyphaga Seu Steleophagas, 18 grams of Herba speranskiae tuberculataes, 16 grams of Herba Lycopodiis, 14 grams of Folium Artemisiae Argyis, 16 grams of Herba Sedi Aizoons, 18 grams of Rhizoma Chuanxiongs, 16 grams of Caulis Spatholobis, 14 grams of Sanguis Draxonis, 16 grams of Scorpio, 9 grams of Scolopendras, 22 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
In said medicine, wherein:
Flos Carthami: promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing;
Radix Angelicae Sinensis: invigorate blood circulation, menstruction regulating and pain relieving, moisturize laxation;
Radix Aconiti: another name goose is spent, the ornamental work of iron, the five poisonous creatures: scorpion, viper, centipede, house lizard, toad, expelling wind and removing dampness, antalgic;
Radix Saposhnikoviae: expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, antipruritic;
Eupolyphaga Seu Steleophaga: another name Eupolyphaga Seu Steleophaga, eupolyphaga, DIWUGUI, female ground beetle, removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones;
Herba speranskiae tuberculatae: claim again Herba Viciae Amoenae, the bean seedling that falls, mountain Semen sojae atricolor, wind-damp dispelling, invigorates blood circulation, relaxing muscles and tendons, pain relieving;
Herba Lycopodii: claim again Radix et Rhizoma Smilacis Ripariae, large along muscle rattan, Radix Schisandrae Micranthae, the Radix Stemonae is stretched muscle, expelling wind and cold. dehumidifying detumescence, relaxing muscles and tendons and activating QI and blood in the collateral;
Folium Artemisiae Argyi: dispersing cold for relieving pain, warming the meridian for stopping bleeding;
Herba Sedi Aizoon: another name Herba Senecionis Chrysanthemoidis, Radix Notoginseng, blood mountain grass, pouring in June, Sedum spectabile Boreau, Radix gynurae segeti, careless Radix Notoginseng, Radix Gynurae, detumescence, analgesic therapy.Hemostasis, blood stasis dispelling;
Rhizoma Chuanxiong: blood circulation promoting and blood stasis dispelling; Activating QI to alleviate the depression; Wind-expelling pain-stopping;
Caulis Spatholobi: enrich blood, invigorate blood circulation, dredging collateral;
Sanguis Draxonis: promoting blood circulation to remove blood stasis for oral administration, analgesic therapy, external hemostasia and promoting granulation, sore;
Scorpio: have another name called Scorpio, Scorpio, Scorpio, endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain;
Scolopendra: endogenous wind stopping relieving convulsion, detoxify, move back inflammation and control skin ulcer;
Rhizoma Drynariae: the kidney invigorating bone strengthening, continues and hinder pain relieving.
Effective combination of said medicine, supports mutually, has blood circulation promoting and blood stasis dispelling, anti-inflammatory analgetic, the effect of network of relaxing of stimulating the menstrual flow, and is effective to treat hyperosteogeny, prolapse of lumbar intervertebral disc, has obtained through clinical experiment the effect that another people is satisfied, and relevant experimental data is as follows:
One, select the standard of case
Bone matrix hyperplasia is called again hyperplastic osteoarthritis, osteoarthritis, degenerated arthrosis, senile arthritis, hypertrophiarthritis, is due to the cartilage that forms joint, intervertebral disc, the soft tissue degeneration such as ligament, degenerate, edge, joint forms bony spur, and synovial membrane is plump waits variation, and occurs osteoclasia, cause insecondary hyperosteogeny, cause joint deformity, in the time being subject to abnormal load, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Hyperosteogeny is a kind of frequently-occurring disease, and commonly encountered diseases is particularly commonplace in mid-aged population.
Intervertebral disc prolapse is a kind of frequently-occurring disease, commonly encountered diseases, and it is mainly because of intervertebral disc strain degeneration, and Anular disruption or vertebral pulp are deviate from etc., stimulate or compressing spinal nerves the series of symptoms group that spinal cord etc. cause.Adult's intervertebral disc generation degenerative change, the fibre thickening in fibrous ring, becomes fragile so that eventual failure, makes intervertebral disc lose original elasticity, can not undertake the pressure of originally bearing.In excessive strain, position cataclysm, under action or violence are clashed into sudden force, fibrous ring gets final product outside bulging, outwards outstanding thereby vertebral pulp also can pass through the crack of the fibrous ring of breaking.
All persons that has above-mentioned symptom, all as the standard of selecting case, and give herb liquid of the present invention and treat.
Two, diagnostic criteria
Symptom described in all standards with selection case, and through blood testing and the X-ray examination person of making a definite diagnosis, all diagnosable for suffering from hyperosteogeny, prolapse of lumbar intervertebral disc.
Three, therapeutic scheme
Herb liquid of the present invention is applied to affected part, every day 2-3 time, within 10 days, is a course for the treatment of, after 6 courses for the treatment of, adds up curative effect.
Four, efficacy assessment standard
Cure: transference cure, physical recovery is normal.
Effective: symptom is obviously improved or improved, need to continue medication treatment.
Invalid: symptom is without improvement, or have the trend of increasing the weight of.
Five, statistical procedures
Clinical hyperosteogeny patient 158 people that make a definite diagnosis, prolapse of lumbar intervertebral disc 120 people are treated by therapeutic scheme, its result statistics is as follows:
Figure 2013100105850100002DEST_PATH_IMAGE002
At experimental session, without finding that there is any untoward reaction.
Six, conclusion
Shown by above-mentioned situation, herb liquid drug safety of the present invention, stable curative effect is reliable, therapeutic effect is good, and effective percentage, up to more than 93%, is the active drug for the treatment of hyperosteogeny, prolapse of lumbar intervertebral disc, having good clinical meaning, is the innovation on treatment hyperosteogeny, prolapse of lumbar intervertebral disc medicine.

Claims (6)

1. a treatment hyperosteogeny, the external application Chinese medicine liquid of prolapse of lumbar intervertebral disc, it is characterized in that, raw material Chinese medicine by following weighing scale is made: Flos Carthami 45-55 gram, Radix Angelicae Sinensis 27-33 gram, Radix Aconiti 8-12 gram, Radix Saposhnikoviae 13-17 gram, Eupolyphaga Seu Steleophaga 13-17 gram, Herba speranskiae tuberculatae 17-23 gram, Herba Lycopodii 13-17 gram, Folium Artemisiae Argyi 13-17 gram, Herba Sedi Aizoon 13-17 gram, Rhizoma Chuanxiong 17-23 gram, Caulis Spatholobi 13-17 gram, Sanguis Draxonis 13-17 gram, Scorpio 13-17 gram, Scolopendra 8-12 gram, Rhizoma Drynariae 17-23 gram, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
2. treatment hyperosteogeny according to claim 1, the external application Chinese medicine liquid of prolapse of lumbar intervertebral disc, it is characterized in that, Chinese medicine by following weighing scale is made: 50 grams, Flos Carthami, 30 grams of Radix Angelicae Sinensis, 10 grams of Radix Aconitis, 15 grams of Radix Saposhnikoviaes, 15 grams of Eupolyphaga Seu Steleophagas, 20 grams of Herba speranskiae tuberculataes, 15 grams of Herba Lycopodiis, 15 grams of Folium Artemisiae Argyis, 15 grams of Herba Sedi Aizoons, 20 grams of Rhizoma Chuanxiongs, 15 grams of Caulis Spatholobis, 15 grams of Sanguis Draxonis, 15 grams of Scorpio, 10 grams of Scolopendras, 20 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
3. treatment hyperosteogeny according to claim 1, the external application Chinese medicine liquid of prolapse of lumbar intervertebral disc, it is characterized in that, Chinese medicine by following weighing scale is made: 45 grams, Flos Carthami, 27 grams of Radix Angelicae Sinensis, 8 grams of Radix Aconitis, 13 grams of Radix Saposhnikoviaes, 13 grams of Eupolyphaga Seu Steleophagas, 17 grams of Herba speranskiae tuberculataes, 13 grams of Herba Lycopodiis, 13 grams of Folium Artemisiae Argyis, 13 grams of Herba Sedi Aizoons, 17 grams of Rhizoma Chuanxiongs, 13 grams of Caulis Spatholobis, 13 grams of Sanguis Draxonis, 13 grams of Scorpio, 8 grams of Scolopendras, 17 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
4. treatment hyperosteogeny according to claim 1, the external application Chinese medicine liquid of prolapse of lumbar intervertebral disc, it is characterized in that, Chinese medicine by following weighing scale is made: 55 grams, Flos Carthami, 33 grams of Radix Angelicae Sinensis, 12 grams of Radix Aconitis, 17 grams of Radix Saposhnikoviaes, 17 grams of Eupolyphaga Seu Steleophagas, 23 grams of Herba speranskiae tuberculataes, 17 grams of Herba Lycopodiis, 17 grams of Folium Artemisiae Argyis, 17 grams of Herba Sedi Aizoons, 23 grams of Rhizoma Chuanxiongs, 17 grams of Caulis Spatholobis, 17 grams of Sanguis Draxonis, 17 grams of Scorpio, 12 grams of Scolopendras, 23 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
5. treatment hyperosteogeny according to claim 1, the external application Chinese medicine liquid of prolapse of lumbar intervertebral disc, it is characterized in that, Chinese medicine by following weighing scale is made: 46 grams, Flos Carthami, 32 grams of Radix Angelicae Sinensis, 9 grams of Radix Aconitis, 16 grams of Radix Saposhnikoviaes, 14 grams of Eupolyphaga Seu Steleophagas, 22 grams of Herba speranskiae tuberculataes, 14 grams of Herba Lycopodiis, 16 grams of Folium Artemisiae Argyis, 14 grams of Herba Sedi Aizoons, 22 grams of Rhizoma Chuanxiongs, 14 grams of Caulis Spatholobis, 16 grams of Sanguis Draxonis, 14 grams of Scorpio, 11 grams of Scolopendras, 18 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
6. treatment hyperosteogeny according to claim 1, the external application Chinese medicine liquid of prolapse of lumbar intervertebral disc, it is characterized in that, Chinese medicine by following weighing scale is made: 53 grams, Flos Carthami, 28 grams of Radix Angelicae Sinensis, 11 grams of Radix Aconitis, 14 grams of Radix Saposhnikoviaes, 16 grams of Eupolyphaga Seu Steleophagas, 18 grams of Herba speranskiae tuberculataes, 16 grams of Herba Lycopodiis, 14 grams of Folium Artemisiae Argyis, 16 grams of Herba Sedi Aizoons, 18 grams of Rhizoma Chuanxiongs, 16 grams of Caulis Spatholobis, 14 grams of Sanguis Draxonis, 16 grams of Scorpio, 9 grams of Scolopendras, 22 grams of Rhizoma Drynariae, said medicine is mixed, at 10-35 ℃, be the brewed 25-35 days of Chinese liquor submergence of 45-65 degree by mass concentration, obtain processed with wine herb liquid.
CN201310010585.0A 2013-01-12 2013-01-12 Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation Expired - Fee Related CN103006962B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310010585.0A CN103006962B (en) 2013-01-12 2013-01-12 Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310010585.0A CN103006962B (en) 2013-01-12 2013-01-12 Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation

Publications (2)

Publication Number Publication Date
CN103006962A CN103006962A (en) 2013-04-03
CN103006962B true CN103006962B (en) 2014-07-02

Family

ID=47956425

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310010585.0A Expired - Fee Related CN103006962B (en) 2013-01-12 2013-01-12 Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation

Country Status (1)

Country Link
CN (1) CN103006962B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104027449B (en) * 2014-06-24 2016-08-24 贵州遵义华源医药保健品有限公司 One treats Fengshi Guanjie pain, medicine for treating hyperosteogeny compositions and preparation method thereof
CN104435767A (en) * 2014-08-29 2015-03-25 刘传法 External application powder for treating lumbar disc herniation and preparation method of external application powder
CN104189399A (en) * 2014-09-22 2014-12-10 郭巧玲 Plaster for treating pain of cervical vertebra, vertebral column, waist and legs and preparation method thereof
CN105106834B (en) * 2015-08-24 2018-11-27 戎钟洪 A kind of HUOLUO YOU and preparation method thereof
CN106619905A (en) * 2017-02-22 2017-05-10 张中起 Traditional Chinese medicine ointment for treating neck shoulder and lumbocrural pain
CN108355065A (en) * 2018-04-02 2018-08-03 窦昭洋 Plaster and preparation method thereof for treating rheumatism, osteoproliferation and the miscellaneous disease of internal medicine
CN109529007A (en) * 2019-01-18 2019-03-29 张振海 A kind of magistral medicines for treating pain
CN112843166A (en) * 2021-03-25 2021-05-28 黑龙江省王家康生物科技有限公司 Health-preserving health-care powder

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101020012A (en) * 2007-03-16 2007-08-22 宗宪山 Recipe of externally applied Chinese medicine liquid prepn for treating rheumatic and rheumatoid pain
CN101274067A (en) * 2007-03-26 2008-10-01 郭茂武 Medical ointment for activating blood circulation, removing stasis, dredging channels and collaterals, releasing swelling and relieving pain, and method for preparing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101020012A (en) * 2007-03-16 2007-08-22 宗宪山 Recipe of externally applied Chinese medicine liquid prepn for treating rheumatic and rheumatoid pain
CN101274067A (en) * 2007-03-26 2008-10-01 郭茂武 Medical ointment for activating blood circulation, removing stasis, dredging channels and collaterals, releasing swelling and relieving pain, and method for preparing the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
《中药治疗骨关节炎的处方用药研究》;高宁阳等;《中国中医骨伤科杂志》;20080531;第16卷(第5期);6-9 *
《骨质增生的中医中药治疗》;李丽华等;《河北医学》;19961231;第2卷(第2期);166-168 *
李丽华等.《骨质增生的中医中药治疗》.《河北医学》.1996,第2卷(第2期),166-168.
高宁阳等.《中药治疗骨关节炎的处方用药研究》.《中国中医骨伤科杂志》.2008,第16卷(第5期),6-9.

Also Published As

Publication number Publication date
CN103006962A (en) 2013-04-03

Similar Documents

Publication Publication Date Title
CN103006962B (en) Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation
CN100376276C (en) Soothe tendons and activating-blood anodyne plaster
CN103463241B (en) Traditional Chinese medicine composition for treating lumbar disc herniation
CN104189871A (en) Medicated wine for treating osteoproliferation
CN103463349A (en) Traditional Chinese medicine composition for treating acute lumbar sprain
CN101757148A (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN103316141B (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN101549137A (en) Chinese medicine preparation for treating bone joint disease
CN103800489B (en) A kind of Chinese medicinal liquor for the treatment of cervical spondylosis and preparation method thereof
CN102626505A (en) Massaging paste based on Chinese medicinal herbs and preparation method thereof
CN101396541A (en) Traditional Chinese medicine for treating cervical spondylosis
CN103251766A (en) Chinese medicine composition, and clinical preparation and preparation method thereof
CN105902969A (en) External-use drug for treating pain in waist and lower extremities, process and application
CN105535902A (en) Externally dressed ointment for treating intervertebral disc herniation
CN111840398A (en) External application traditional Chinese medicine capable of effectively treating neck, shoulder, waist and leg pain
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN102743554B (en) Externally applied plaster treating rheumatic arthralgia
CN103735756A (en) Traditional Chinese medicinal prescription for treating low back and leg pain
CN103040944B (en) External-use traditional Chinese medicine ointment for treating hyperostosis and lumbar disc herniation
CN102430096B (en) Medicament for treating rheumatic or rheumatoid diseases
CN105687570A (en) Traditional Chinese medicinal composition for treating sciatica
CN101721483A (en) Traditional Chinese medicine for treating prolapse of lumbar intervertebral disc
CN104758527A (en) Traditional Chinese medicine composition for treating pain in waists and legs
CN105878639A (en) Anti-hyperosteogeny drug
CN104740003A (en) Traditional Chinese medicine for treating lumbar disc herniation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140702

Termination date: 20170112